Dr. Ajlouni is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Henry Ford Health System
15401 East Jefferson
Grosse Pointe Park, MI 48230Phone+1 313-824-4800Fax+1 313-824-7080
Education & Training
Henry Ford Health/Henry Ford HospitalResidency, Radiation Oncology, 1985 - 1986
Corewell Health East Beaumont (Royal Oak)Residency, Radiation Oncology, 1983 - 1984
Ascension Providence/MSUCHMInternship, Transitional Year, 1982 - 1983
Wayne State University School of MedicineClass of 1982
Certifications & Licensure
MI State Medical License 1987 - 2025
OH State Medical License 1986 - 1988- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma Start of enrollment: 2006 Nov 01
Publications & Presentations
PubMed
- Clinical Outcome in Patients With Early-Stage Small Cell Lung Cancer Treated With Surgery or Radiation in the Absence of Prophylactic Cranial Irradiation: A Single-Cen...Sondos Al Khatib, Khalid Adil, Lonni Schultz, Shirish Gadgeel, Andrew Popoff
Advances in Radiation Oncology. 2023-02-06 - 6 citationsAn Analysis of Clinical Toxic Effects and Quality of Life as a Function of Radiation Dose and Volume After Lung Stereotactic Body Radiation TherapySuneetha Devpura, Aharon M Feldman, Samuel Rusu, Essa Mayyas, Avielle Movsas
Advances in Radiation Oncology. 2021-11-01 - 29 citationsPhase I trial of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for the treatment of metastatic pancreatic cancer.Kenneth N. Barton, Farzan Siddiqui, Robert Pompa, Svend O. Freytag, Gazala Khan
Molecular Therapy Oncolytics. 2021-03-26
Professional Memberships
- Member
- ASTROMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
